| AD | Alzheimer’s disease |
| AMT | Adsorptive-mediated transcytosis |
| Apo-E | Apolipoprotein E |
| APP | Amyloid precursor protein |
| Aβ | β-amyloid |
| BBB | Blood brain barrier |
| bEnd.3 | Immortalised brain endothelial cells |
| CNS | Central nervous system |
| DMEM | Dulbecco’s modified eagle’s medium |
| ELISA | Enzyme-linked immune-sorbent assay |
| FBS | Foetal bovine serum |
| FP | Flurbiprofen |
| FTIR | Fourier transform infra-red |
| G | Generation |
| G0K-FP | Generation 0 lysine dendron-2Flurbiprofen |
| G1K-FP | Generation 1 lysine dendron-4Flurbiprofen |
| GSMs | γ-secretase modulators |
| HPLC | High performance liquid chromatography |
| HUVEC | Human umbilical vein endothelial cells |
| LDH | Lactate dehydrogenase |
| m/z | Mass to charge ratio |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan |
| MW | Molecular weight |
| ND | Neurodegenerative |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| PAMAM | Poly amido amine dendrimers |
| SD | Standard deviation |
| SPPS | Solid phase peptide synthesis |
| TEER | Transepithelial electrical resistance |